| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000021984 |
| Receipt No. | R000025275 |
| Official scientific title of the study | The effect of ankle foot orthosis within peripheral nerve palsy and cerebral palsy patients |
| Date of disclosure of the study information | 2016/04/19 |
| Last modified on | 2016/04/19 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | The effect of ankle foot orthosis within
peripheral nerve palsy and cerebral palsy patients |
|
| Title of the study (Brief title) | The effect of ankle foot orthosis | |
| Region |
|
|
| Condition | ||
| Condition | peripheral nerve palsy, hemiparesis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | he purpose of this study was to compare the effects of AFO on functional ambulation in patients with hemiplegia and unilateral lower-extremity palsy. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Functional ambulation was assessed with AFO and without AFO by 10-meter maximum walking speed (10MMWS) and the distance walked in a 6-minute walking test (6MWT). Functional balance was assessed using the Berg balance scale |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | with AFO | |
| Interventions/Control_2 | without AFO | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | no history of injury or pathology in the uninvolved lower limb; 2) ability to walk independently or with supervision for 6 minutes, both with and without AFO; and 3) wearing AFO for more than 50% of the walking time | |||
| Key exclusion criteria | The patients whom it does not apply to as above | |||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Yukihide Nishimura |
| Organization | Wakayama Medical University |
| Division name | Department of Rehabilitation Medicine |
| Address | 811-1 Kimiidera, Wakayama city,Wakayama 641-8509, Japan |
| TEL | 073-441-0664 |
| yuki-n@wakayama-med.ac.jp | |
| Public contact | |
| Name of contact person | Yukihide Nishimura |
| Organization | Wakayama Medical University |
| Division name | Department of Rehabilitation Medicine |
| Address | 811-1 Kimiidera, Wakayama city,Wakayama 641-8509, Japan |
| TEL | 073-441-0664 |
| Homepage URL | |
| yuki-n@wakayama-med.ac.jp | |
| Sponsor | |
| Institute | Wakayama Medical University |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025275 |